Relationships between seizure activity and cyclic nucleotide levels in brain

Area of Science:

• Neuroscience
• Neurochemistry
• Pharmacology

Background:

• Cyclic nucleotides like cyclic AMP (cAMP) and cyclic guanosine monophosphate (cGMP) are crucial second messengers in the central nervous system (CNS).
• Their roles in neuronal excitability and the pathophysiology of seizures are not fully elucidated.
• Pentylenetetrazol (PTZ) is a well-established chemoconvulsant used to induce seizure-like activity in animal models.

Purpose of the Study:

• To investigate the differential effects of pentylenetetrazol on CNS levels of cAMP and cGMP.
• To determine the relationship between PTZ-induced changes in cyclic nucleotide levels and seizure activity.
• To explore the potential roles of cGMP and cAMP in seizure genesis and termination.

Main Methods:

• Administration of pentylenetetrazol (sub-convulsant and convulsant doses) to mice and guinea pigs.
• Measurement of regional CNS levels of cyclic AMP (cAMP) and cyclic GMP (cGMP) in brain regions including the cerebral cortex, hippocampus, striatum, and cerebellum.
• Monitoring of electroencephalogram (EEG) activity and behavioral observations to assess seizure occurrence and severity.

Main Results:

• Pentylenetetrazol significantly increased cGMP levels in all examined brain regions, irrespective of whether sub-convulsant or convulsant doses were used.
• cAMP levels were elevated only in response to PTZ concentrations that induced overt seizures or epileptiform EEG activity.
• These increases in cAMP were observed in all regions except the striatum.

Conclusions:

• Elevated CNS cGMP levels can be induced by epileptogenic stimuli independently of seizure discharge.
• Accumulation of CNS cAMP is secondary to and requires seizure activity.
• These findings support a hypothesis where cGMP may be involved in seizure initiation/propagation, while cAMP might play a role in seizure attenuation or termination.